Clinical impact of prostate biopsy undergrading in an academic and community setting.

Journal: World journal of urology
Published Date: Oct 1, 2016

Abstract

PURPOSE: To evaluate whether the rate of Gleason score (GS) upgrade on final pathology, the rate of positive surgical margins (PSM) and the rate of biochemical recurrence (BCR) after radical prostatectomy (RP) were different if prostate biopsy (PB) was graded by community pathologists (CP) as compared to specialized uro-pathologists (UP).

Authors

  • Ashkan Mortezavi
    Department of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstr.10, 8091, Zurich, Switzerland. Ashkan.Mortezavi@usz.ch.
  • Etienne Xavier Keller
    Department of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstr.10, 8091, Zurich, Switzerland.
  • Cédric Poyet
    Department of Urology University Hospital Zurich Zurich Switzerland.
  • Thomas Hermanns
    Department of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstr.10, 8091, Zurich, Switzerland.
  • Karim Saba
    Department of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstr.10, 8091, Zurich, Switzerland.
  • Marco Randazzo
    Department of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstr.10, 8091, Zurich, Switzerland.
  • Christian Daniel Fankhauser
    Department of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstr.10, 8091, Zurich, Switzerland.
  • Peter J Wild
    Institute of Surgical Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Holger Moch
    Institute of Surgical Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Tullio Sulser
    Department of Urology, University Hospital Zurich, University of Zurich, Frauenklinikstr.10, 8091, Zurich, Switzerland.
  • Daniel Eberli
    Department of Urology University Hospital Zurich Zurich Switzerland.

Keywords

External Resources

Popular Topics
Recent Journals